Treatment of Blastic Phase Chronic Myelogenous Leukemia

For information about the treatments listed below, see the Treatment Option Overview section.

Treatment of blastic phase chronic myelogenous leukemia may include the following:

• Targeted therapy with a tyrosine kinase inhibitor (imatinib mesylate, dasatinib, nilotinib, bosutinib).
• High-dose chemotherapy.
• Donor stem cell transplant.
• Chemotherapy as palliative therapy to relieve symptoms and improve quality of life.
• A clinical trial of a new treatment.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.